| Falk, Volkmar |
| Recruiting | 3 | 3200 | Europe, Canada, US | Antiplatelet-only strategy, Oral Anticoagulant plus background antiplatelet therapy | Icahn School of Medicine at Mount Sinai, National Heart, Lung, and Blood Institute (NHLBI), Vanderbilt University Medical Center | Atrial Fibrillation, Stroke, Bleeding | 08/26 | 08/26 | | |
| Active, not recruiting | N/A | 500 | Europe | Minimally-Invasive Segmental Artery Coil-Embolization | University of Leipzig, European Commission, German Research Foundation, Universidad de Granada, European Clinical Research Infrastructure Network, Modus Research and Innovation Limited, Rigshospitalet, Denmark, European Society of Cardiology, Baylor College of Medicine, University of Pennsylvania | Aortic Aneurysm, Thoracoabdominal | 06/25 | 06/25 | | |
NCT02387112: Early Versus Emergency Left Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation |
|
|
| Active, not recruiting | N/A | 102 | Europe | Early VAD implantation | German Heart Institute, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Helmholtz Zentrum München, University Medicine Greifswald, University of Göttingen | End Stage Heart Disease | 03/24 | 12/24 | | |
| Active, not recruiting | N/A | 14 | Europe | Revivent TC Ventricular Enhancement System, GDMT | BioVentrix, Imaging Clinical Trial Services GmbH, Meditrial Europe Ltd. | Ischemic Cardiomyopathy, Heart Failure | 12/24 | 12/27 | | |
METASAR, NCT05941455: A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve |
|
|
| Not yet recruiting | N/A | 155 | Europe | Venus-Neo Surgical Aortic Valve | Jilin Venus Haoyue Medtech Limited | Aortic Valve Disease, Cardiovascular Diseases | 10/25 | 10/29 | | |
| Recruiting | N/A | 360 | Europe | Transcatheter tricuspid valve treatment (TTVT) | LMU Klinikum, Heart and Diabetes Center North Rhine-Westphalia, University Medical Center Mainz, Heart Center Leipzig - University Hospital, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), University of Leipzig | Heart Failure Attributable to Severe Tricuspid Regurgitation | 03/26 | 03/27 | | |
PRIMARY, NCT05051033: Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds |
|
|
| Recruiting | N/A | 450 | Europe, Canada, US | Mitral valve repair, Mitral valve surgery, Transcatheter edge-to-edge repair, TEER | Annetine Gelijns, National Heart, Lung, and Blood Institute (NHLBI) | Mitral Valve Regurgitation | 11/28 | 11/30 | | |
